Author: Manning Cheng

Vancouver, Canada (May 13, 2022) – Innovation and differentiation continue to propel precision prescribing software company GenXys with accolades and commercial success in the US market. GenXys recently was named the 2022 Best Overall Medical Data Solution Provider by MedTech Breakthrough…

Pharmacogenetic Testing & EHR Integration Help Avoid Trial-and-Error Prescribing Vancouver, Canada (April 21, 2022): GenXys Health Care Systems, Inc., the global leader in precision prescribing software with embedded pharmacogenetic data, added a record five pharmacogenetic companies as customers in the first…

Adverse Drug Events (ADEs) annually account for more than 1 million emergency department visits, 2.2 million hospital admissions, 3.5 million physician office visits, and $136 billion in U.S. health care costs. In addition to being the #1 most costly hospital-acquired condition,…

References 1 – https://www.futuremedicine.com/doi/10.2217/pgs-2019-0134 2 – https://www.cdc.gov/medicationsafety/adult_adversedrugevents.html 3 – https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-14-73 4 – https://pubmed.ncbi.nlm.nih.gov/24798722/ 5 – https://www.fda.gov/drugs/science-and-research-drugs/table-pharmacogenomic-biomarkers-drug-labeling 6 – https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0255642 7 – https://www.reuters.com/article/us-bristol-myers-sanofi-plavix-idUSKBN2AF1YI 8 – https://www.einnews.com/pr_news/560810526/pharmacogenomics-market-is-estimated-to-reach-usd-11-97-billion-by-2028-emergen-research#:~:text=RESEARCH%20%2D%20EIN%20Presswire-,Pharmacogenomics%20Market%20is%20estimated%20to%20reach,billion%20by%202028%3A%20EMERGEN%20RESEARCH&text=Pharmacogenomics%20Market%20trends%20%E2%80%93%20Growing%20demand%20for%20personalized%20therapy